Tuesday, January 10, 2006


USA TODAY Cover Story Features Lipid Sciences' HDL Therapy in ' ... (Hep C Chronic Fatigue)


USA TODAY Cover Story Features Lipid Sciences' HDL Therapy in ' ...
Market Wire (press release) - 8 hours ago... Conditions that could potentially be impacted by this technology include HIV, Hepatitis B and Hepatitis C, West Nile, SARS and influenza. ...

Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug ...
Finanzen.net, Germany - Jan 3, 2006... International (NYSE:VRX) todayannounced that it has completed its acquisition of the United Statesand Canadian rights to the hepatitis C drug Infergen(R ...

Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug ...
Business Wire (press release), CA - Jan 3, 2006... International (NYSE:VRX) today announced that it has completed its acquisition of the United States and Canadian rights to the hepatitis C drug Infergen(R ...

MedMira Granted Hepatitis C Patent in Europe
PR Newswire (press release), NY - Jan 3, 2006... first major patent on its rapid diagnostic technology in Europe, and paves the way for the world's first combination HIV and Hepatitis C instant rapid test. ...

Two new cases of hepatitis C this year
Shetland Times, UK - Dec 30, 2005THE NUMBER of people in Shetland diagnosed with the hepatitis C virus is running at just over a quarter of the national average rate. ...